Jeff Evans has been editor of Rheumatology News/MDedge Rheumatology and the EULAR Congress News since 2013. He started at Frontline Medical Communications in 2001 and was a reporter for 8 years before serving as editor of Clinical Neurology News and World Neurology, and briefly as editor of GI & Hepatology News. He graduated cum laude from Cornell University (New York) with a BA in biological sciences, concentrating in neurobiology and behavior.
News
Lower Diabetes Risk Seen in Lupus Patients Using Hydroxychloroquine
Key clinical point: Cumulative HCQ use of at least 129 g may be associated with lower risk of diabetes in patients with lupus and concomitant...
News
Lower diabetes risk seen in lupus patients using hydroxychloroquine
Key clinical point: Cumulative HCQ use of at least 129 g may be associated with lower risk of diabetes in patients with lupus and concomitant...
News
Running history doesn’t contribute to knee OA risk
Key clinical point: There’s no need to restrict habitual running in people who don’t already have knee OA. Major finding: Symptomatic radiographic...
News
OA patients benefit long term from exercise or manual therapy
Key clinical point: Prescribing exercise therapy or manual therapy to patients in various stages of OA can provide long-term benefit in addition...
News
Disease activity, not lipid levels, appear to affect CV risk with tocilizumab
Key clinical point: Disease activity, rather than lipid levels, is an independent predictor of cardiovascular event risk during treatment with...
